GO
Loading...

Enter multiple symbols separated by commas

Search results for "OREX"

REFINE RESULTS

SEARCH RESULTS

About 2 results. Sort By: Date | Relevance
UPDATE 1-Orexigen says obesity drug safety trial terminated

May 12- A trial assessing the cardiovascular safety of obesity drug Contrave, made by Orexigen Therapeutics Inc and Takeda Pharmaceutical Co Ltd, was terminated on Tuesday due to unauthorized release of study data. A statement from Cleveland Clinic, which was conducting the trial, said the study was being halted as unauthorized release of trial data by...
Source: Reuters
Orexigen says obesity drug safety trial terminated

May 12- Orexigen Therapeutics Inc and its partner Takeda Pharmaceutical Co said they were terminating a trial assessing the cardiovascular safety of obesity drug, Contrave. Orexigen Therapeutics shares were down 12.5 percent in after market trading after falling 13.6 percent in regular trading on the Nasdaq on Tuesday. A statement from Cleveland Clinic,...
Source: Reuters